Edwards Lifesciences (EW) Shares Issued (2009 - 2026)

Edwards Lifesciences has reported Shares Issued for 18 years, with the latest figure at $68.9 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Issued rose 38.08% year-over-year to $68.9 million; the trailing twelve-month figure through Mar 2026 stood at $193.1 million (up 15.42% YoY), and the FY2025 full-year result was $174.1 million, down 3.01% from the prior year.
• Shares Issued for Q1 2026 stood at $68.9 million, up from $32.3 million in the prior quarter.
• The five-year high for Shares Issued was $68.9 million in Q1 2026, with the low at $27.5 million in Q4 2022.
• Average Shares Issued over 5 years is $43.5 million, with a median of $37.5 million recorded in 2022.
• Year-over-year, Shares Issued jumped 48.21% in 2024 and decreased 19.65% in 2025.
• Tracing EW's Shares Issued over 5 years: stood at $27.5 million in 2022, then grew by 20.73% to $33.2 million in 2023, then dropped by 13.86% to $28.6 million in 2024, then climbed by 12.94% to $32.3 million in 2025, then jumped by 113.31% to $68.9 million in 2026.
• The last three Shares Issued figures came in at $68.9 million (Q1 2026), $32.3 million (Q4 2025), and $34.7 million (Q3 2025), per Business Quant data.

Peer Comparison